Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00739921 · ClinicalTrials.gov registry record · NA

The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA

A NA study of Sinusitis and Nasal Polyps, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
260
Enrollment target
1
Study location

NCT00739921: Completed NA study of Sinusitis and Nasal Polyps, sponsored by University of California, San Francisco.

NCT00739921 is a NA study of Sinusitis and Nasal Polyps that has completed, run by University of California, San Francisco. The registered enrollment target is 260 participants, above the 109-participant average among 12 other Sinusitis trials with a reported enrollment target (139% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00739921, a NA study of Sinusitis and Nasal Polyps, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
260 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - 20 Questions (SNOT-20).

Conditions Studied

Interventions

  • PROCEDURE Nasal swab under endoscopic guidance

Study Locations (1)

California

  • University of California, San Francisco, Dept of Otolaryngology-HNS - San Francisco

Trial Details

FieldValue
Enrollment Target 260 participants
Start Date 2006-06
Est. Completion 2015-05
Phase NA

What the finished NCT00739921 record still lists

NCT00739921 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, above the 109-participant average among 12 other Sinusitis trials with a reported enrollment target (139% higher).

The record links to 2 conditions, with Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which Nasal swab under endoscopic guidance is the first listed.

NCT00739921 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00739921 about?

NCT00739921 is a clinical study titled "The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA". The objective of this study is to determine whether the amount or type of fungal DNA present in the nose and home environment can be correlated with the outcomes of the following quality of life (QOL) instruments: Medical Outcomes Study 36-item Short Form (SF-36) and the Sino-Nasal Outcomes Study - ...

What is the current status of trial NCT00739921?

This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2006-06. Estimated completion is 2015-05.

What conditions does trial NCT00739921 study?

This clinical trial studies the following conditions: Sinusitis, Nasal Polyps.

What interventions are being tested in trial NCT00739921?

The interventions under investigation include: Nasal swab under endoscopic guidance (PROCEDURE).

Who is sponsoring clinical trial NCT00739921?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00739921 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00739921's enrollment target sits among peer trials

260 3rd of 12 higher than 10 of 12 other Sinusitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02283996 · 260 participants · Phase 4

    Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment

  • NCT03276793 · 260 participants · NA

    Brain Connectivity in Depression

  • NCT03407469 · 260 participants

    Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

  • NCT03713125 · 260 participants · NA

    Executive Function in Early Childhood

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00739921, the US trial registry maintained by the National Library of Medicine. NCT00739921 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.